1887

Journal of General Virology header logo

Volume 75, Issue 12

Human cytomegalovirus structural proteins Free

Preview this article:
Preview Magnify

There is no abstract available.

  • Published Online:
© The Journal of General Virology 1994
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-12-3287
1994-12-01
2022-05-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/12/JV0750123287.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-12-3287&mimeType=html&fmt=ahah

References

  1. Adlish J. D., Lahijani R. S., St Jeor S. C. S. 1990; Identification of a putative cell receptor for human cytomegalovirus. Virology 176:337–345
     [Google Scholar]
  2. Alford C. A., Britt W. J. 1993; Cytomegalovirus. In The Human Herpesviruses pp. 227–255 Roizman B., Whitley R. J., Lopez C. Edited by New York: Raven Press;
     [Google Scholar]
  3. Amadei C., Tardy-Panit M., Coulon M., Cabau N., Boué A., Michelson S. 1983; Kinetic study of the development and localization of human cytomegalovirus-induced antigens using monoclonal antibodies. Annates de L’lnstitut Pasteur/Virologie 134E:165–180
     [Google Scholar]
  4. Baboonian C., Blake K., Booth J. C., Wiblin C. N. 1989; Complement-independent neutralizing monoclonal antibody with differential reactivity for strains of human cytomegalovirus. Journal of Medical Virology 29:139–145
     [Google Scholar]
  5. Baines J. D., Roizman B. 1991; The open reading frames UL3, UL4, UL10, and UL16 are dispensable for the replication of herpes simplex virus 1 in cell culture. Journal of Virology 65:938–944
     [Google Scholar]
  6. Baines J. D., Roizman B. 1993; The UL10 gene of herpes simplex virus 1 encodes a novel viral glycoprotein, gM, which is present in the virion and in the plasma membrane of infected cells. Journal of Virology 67:1441–1452
     [Google Scholar]
  7. Banks T., Huo B., Kousoulas K., Spaete R., Pachl C., Pereira L. 1989; A major neutralizing domain maps within the carboxyl-terminal half of the cleaved cytomegalovirus B glycoprotein. Journal of General Virology 70:978–985
     [Google Scholar]
  8. Barr P. J. 1991; Mammalian subtilisins: the long-sought dibasic processing endoproteases. Cell 66:1–3
     [Google Scholar]
  9. Basgoz N., Qadri I., Navarro D., Sears A., Lennette E., Youngblom J., Pereira L. 1992; The amino terminus of human cytomegalovirus glycoprotein B contains epitopes that vary among strains. Journal of General Virology 73:983–988
     [Google Scholar]
  10. Batterson W., Furlong D., Roizman B. 1983; Molecular genetics of herpes simplex virus. VII. Further characterization of a temperature-sensitive mutant defective in release of viral DNA and in other stages of the viral reproductive cycle. Journal of Virology 45:397–407
     [Google Scholar]
  11. Baum E. Z., Bebernitz G. A., Hulmes J. D., Muzithras V. P., Jones T. R., Gluzman Y. 1993; Expression and localization of HCMV UL80-encoded protease: identification of autoproteolytic sites. Journal of Virology 67:497–506
     [Google Scholar]
  12. Beck S., Barrell B. G. 1988; Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens. Nature; London: 331269–272
     [Google Scholar]
  13. Beersma M. F. C., Wertheim-Vandillen P. M. E., Geelen J. L. M. C., Feltkamp T. E. W. 1991; Expression of HLA class I heavy chains and β 2-microglobulin does not affect human cytomegalovirus infectivity. Journal of General Virology 72:2757–2764
     [Google Scholar]
  14. Benko D. M., Gibson W. 1986; Primate cytomegalovirus glycoproteins: lectin-binding properties and sensitivities to glyco-sidases. Journal of Virology 59:703–713
     [Google Scholar]
  15. Benko D. M., Haltiwanger R. S., Hart G. W., Gibson W. 1988; Virion basic phosphoprotein from human cytomegalovirus contains O-linked N-acetylglucosamine. Proceedings of the National Academy of Sciences, U.S.A 85:2573–2577
     [Google Scholar]
  16. Berencsi K., Rando R. F., DeTaisne C., Paoletti E., Plotkin S. A., Gönczöl E. 1993; Murine cytotoxic T cell response specific for human cytomegalovirus glycoprotein B (gB) induced by adenovirus and vaccinia virus recombinants expressing gB. Journal of General Virology 74:2507–2512
     [Google Scholar]
  17. Bogner E., Reschke M., Reis B., Britt W., Radsak K. 1992; Recognition of compartmentalized intracellular analogs of glycoprotein H of human cytomegalovirus. Archives of Virology 126:67–80
     [Google Scholar]
  18. Bogner E., Reschke M., Reis B., Richter A., Mockenhaupt T., Radsak K. 1993; Identification of the gene product encoded by ORF UL56 of the human cytomegalovirus. Virology 196:290–293
     [Google Scholar]
  19. Bradshaw P. A., Duran M., Lee E., Young L., Reyes G. R., Perkins S., Pande H., Foung S. K. H. 1991; Anti-CMV human monoclonal antibodies epitope identification and immune response analysis. In Progress in Cytomegalovirus Research pp. 157–160 Landini M. P. Edited by Amsterdam: Elsevier;
     [Google Scholar]
  20. Braun D. K., Batterson W., Roizman B. 1984; Identification and genetic mapping of a herpes simplex virus capsid protein that binds DNA. Journal of Virology 50:645–648
     [Google Scholar]
  21. Britt W. J. 1984; Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology 135:369–378
     [Google Scholar]
  22. Britt W. J. 1991; Recent advances in the identification of significant human cytomegalovirus-encoded proteins. Transplantation Proceedings 23: Supplement 3 64–69
     [Google Scholar]
  23. Britt W. J., Auger D. 1985; Identification of a 65,000 dalton virion envelope protein of human cytomegalovirus. Virus Research 4:31–36
     [Google Scholar]
  24. Britt W. J., Auger D. 1986; Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus. Journal of Virology 58:185–191
     [Google Scholar]
  25. Britt W. J., Vugler L. 1987; Structural and immunological characterization of the intracellular forms of an abundant 68000 M r human cytomegalovirus protein. Journal of General Virology 68:1897–1907
     [Google Scholar]
  26. Britt W. J., Vugler L. G. 1992; Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116). Journal of Virology 66:6747–6754
     [Google Scholar]
  27. Britt W. J., Vugler L. G. 1989; Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. Journal of Virology 63:403–410
     [Google Scholar]
  28. Britt W. J., Vugler L., Stephens E. B. 1988; Induction of complement-dependent and independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-l 16 (gB). Journal of Virology 62:3309–3318
     [Google Scholar]
  29. Britt W. J., Vugler L., Butfiloski E. J., Stephens E. B. 1990; Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. Journal of Virology 64:1079–1085
     [Google Scholar]
  30. Browne H., Smith G., Beck S., Minson T. 1990; A complex between the MHC class I homologue encoded by human cytomegalovirus and β 2-microglobulin. Nature; London: 347770–772
     [Google Scholar]
  31. Browne H., Churcher M., Minson T. 1992; Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted. Journal of Virology 66:6784–6787
     [Google Scholar]
  32. Brücher K. H., Garten W., Klenk H. D., Shaw E., Radsak K. 1990; Inhibition of endoproteolytic cleavage of cytomegalovirus (HCMV) glycoprotein B by palmitoyl-peptidyl-chloromethyl ketone. Virology 178:617–620
     [Google Scholar]
  33. Chang C. -P., Vesole D. H., Nelson J., Oldstone M. B. A., Stinski M. F. 1989a; Identification and expression of a human cytomegalovirus early glycoprotein. Journal of Virology 63:3330–3337
     [Google Scholar]
  34. Chang C. -P., Malone C. L., Stinski M. F. 1989b; A human cytomegalovirus early gene has three inducible promoters that are regulated differentially at various times after infection. Journal of Virology 63:281–290
     [Google Scholar]
  35. Chardonnet Y., Lery X., Revillard J. P. 1983; Identification of shared antigenic determinants of different polypeptides from Davis and Towne cytomegalovirus strains with monoclonal antibodies. Medical Microbiology and Immunology 172:171–180
     [Google Scholar]
  36. Charpentier B., Michelson S., Martin B. 1986; Definition of HCMV specific target antigens recognized by cytotoxic T cells generated in vitro by using an autologous lymphocyte system. Journal of Immunology 137:330–336
     [Google Scholar]
  37. Chee M., Rudolph S. A., Plachter B., Barrell B., Jahn G. 1989; Identification of the major capsid protein gene of human cytomegalovirus. Journal of Virology 63:1345–1353
     [Google Scholar]
  38. Chee M. S., Bankier A. T., Beck S., Bohni R., Brown C. M., Cerny R., Horsnell T., Hutchinson C. A. III Kouzarides T., Martignetti J. A., Preddie E., Satchwell S. C., Tomlinson P., Weston K. M., Barrell B. G. 1990; Analysis of the proteincoding content of the sequence of human cytomegalovirus strain AD169. Current Topics in Microbiology and Immunology 154:125–169
     [Google Scholar]
  39. Chou S. 1992a; Comparative analysis of sequence variation in gpl 16 and gp55 components of human cytomegalovirus. Virology 188:388–390
     [Google Scholar]
  40. Chou S. 1992b; Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus. Journal of Infectious Diseases 166:604–607
     [Google Scholar]
  41. Chou S., Dennison K. M. 1991; Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. Journal of Infectious Diseases 163:1229–1234
     [Google Scholar]
  42. Clark B. R., Zaia J. A., Balce-Directo L., Ting Y. P. 1984; Isolation and partial characterization of a 64,000 dalton glycoprotein of human cytomegalovirus. Journal of Virology 49:279–282
     [Google Scholar]
  43. Compton T. 1993; An immortalized human fibroblast cell line is permissive for human cytomegalovirus infection. Journal of Virology 67:3644–3648
     [Google Scholar]
  44. Cooper N. R., Nowlin D., Taylor H. P., Compton T. 1991; Cellular receptor for human cytomegalovirus. Transplantation Proceedings 23: Supplement 3 56–59
     [Google Scholar]
  45. Cranage M. P., Kouzarides T., Bankier A. T., Satchwell S., Weston K., Tomlinson P., Barrell B., Hart H., Bell S. E., Minson A. C., Smith G. L. 1986; Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO Journal 5:3057–3063
     [Google Scholar]
  46. Cranage M. P., Smith G. L., Bell S. E., Hart H., Brown C., Bankier A. T., Tomlinson P., Barrell B. G., Minson T. C. 1988; Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H. Journal of Virology 62:1416–1422
     [Google Scholar]
  47. Cremer N. E., Cossen C. K., Shell G. R., Pereira L. 1985; Antibody response to cytomegalovirus polypeptides captured by monoclonal antibodies on the solid phase in enzyme immunoassays. Journal of Clinical Microbiology 21:517–521
     [Google Scholar]
  48. Davis M. G., Huang E. S. 1985; Nucleotide sequence of a human cytomegalovirus DNA fragment encoding a 67-kilodalton phos-phorylated viral protein. Journal of Virology 56:7–11
     [Google Scholar]
  49. Davis M. G., Mar E. C., Wu Y. M., Huang E. S. 1984; Mapping and expression of a human cytomegalovirus major viral protein. Journal of Virology 52:129–135
     [Google Scholar]
  50. Degnin C. R., Schleiss M. R., Cao J., Geballe A. P. 1993; Translational inhibition mediated by a short upstream open reading frame in the human cytomegalovirus gpUL4 (gp48) transcript. Journal of Virology 67:5514–5521
     [Google Scholar]
  51. Depto A. S., Stenberg R. M. 1989; Regulated expression of the human cytomegalovirus pp65 gene: octamer sequence in the promoter is required for activation by viral gene products. Journal of Virology 63:1232–1238
     [Google Scholar]
  52. Depto A. S., Stenberg R. M. 1992; Functional analysis of the true late human cytomegalovirus pp28 upstream promoter: cis-acting elements and viral trans-acting proteins necessary for promoter activation. Journal of Virology 66:3241–3246
     [Google Scholar]
  53. Edwards R. L. 1976; Structural proteins of human cytomegalovirus. Yale Journal of Biology and Medicine 49:65–66
     [Google Scholar]
  54. Ehrlich P. H., Harfeldt K. E., Justice J. C., Moustafa Z. A., Ostberg L. 1987; Rhesus monkey responses to multiple injections of human monoclonal antibodies. Hybridoma 6:151–160
     [Google Scholar]
  55. Ehrlich P. H., Moustafa Z. A., Justice J. C., Harfeldt K. E., Ostberg L. 1988; Further characterization of the fate of human monoclonal antibodies in rhesus monkeys. Hybridoma 7:385–395
     [Google Scholar]
  56. Farrar G. H., Oram J. D. 1984; Characterization of human cytomegalovirus envelope glycoproteins. Journal of General Virology 65:1991–2001
     [Google Scholar]
  57. Farrar G. H., Greenaway P. J. 1986; Characterization of glycoprotein complexes present in human cytomegalovirus envelopes. Journal of General Virology 67:1469–1473
     [Google Scholar]
  58. Faucon-Biguet N., Siqueira-Linhares I., Chardonnet Y., Revillard J. P. 1986; Sequential changes in CMV antigenic pattern during infection of renal transplant patients. Microbios 45:71–80
     [Google Scholar]
  59. Fiala M., Honess R. W., Heiner D. C., Heine J. W., Murnane J., Wallace R., Guze L. B. 1976; Cytomegalovirus proteins. I. Polypeptides of virions and dense bodies. Journal of Virology 19:243–254
     [Google Scholar]
  60. Fiala M., Heiner D. C., Murnane J., Guze L. B. 1978; Cytomegalovirus proteins. II. Polypeptide composition of complement fixing antigen. Journal of Medical Virology 2:39–44
     [Google Scholar]
  61. Forman S. J., Zaia J. A., Clark B. R., Wright C. L., Mills B. J., Pottathil R., Racklin B. C., Gallagher M. T., Welte K., Blume K. G. 1985; A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigen. Journal of Immunology 134:3391–3395
     [Google Scholar]
  62. Foung S. K. H., Perkins S., Bradshaw P., Rowe J., Rabin L. B., Reyes G. R., Lennette E. T. 1989; Human monoclonal antibodies to human cytomegalovirus. Journal of Infectious Diseases 159:436–443
     [Google Scholar]
  63. Geballe A. P., Leach F. S., Mocarski E. S. 1986; Regulation of cytomegalovirus late gene expression: γ genes are controlled by posttranscriptional events. Journal of Virology 57:864–874
     [Google Scholar]
  64. Gerna G., Revello M. G., Percivalle E., Morini F. 1992; Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. Journal of Clinical Microbiology 30:1232–1237
     [Google Scholar]
  65. Gibson W. 1983; Protein counterparts of human and simian cytomegaloviruses. Virology 128:391–406
     [Google Scholar]
  66. Gibson W. 1991; Cytomegalovirus protein structure and function. In Progress in Cytomegalovirus Research pp. 357–370 Landini M. P. Edited by Amsterdam: Elsevier;
     [Google Scholar]
  67. Gibson W., Irmiere A. 1984; Selection of particles and proteins for use as human cytomegalovirus vaccine. In Birth Defects March of Dimes Birth Defects Foundation, Original Articles Series 20 pp. 305–324 New York: Alan R. Liss;
     [Google Scholar]
  68. Gibson W., Marcy A. I., Comolli J. C., Lee J. 1990; Identification of precursor of cytomegalovirus capsid assembly protein and evidence that processing results in loss of its carboxy-terminal end. Journal of Virology 64:1241–1249
     [Google Scholar]
  69. Giugni T. D., Churchill M. A., Pande H., Campo K., Guha M., Zaia J. A. 1992; Expression in insect cells and immune reactivity of a 28K tegument protein of human cytomegalovirus. Journal of General Virology 73:2367–2374
     [Google Scholar]
  70. Goins W. F., Stinski M. F. 1986; Expression of a human cytomegalovirus late gene is posttranscriptionally regulated by a 3′-end-processing event occurring exclusively late after infection. Molecular Cell Biology 6:202–213
     [Google Scholar]
  71. Gold D., Ashley R., Handsfield H. H., Verdon M., Leach L., Millo J., Drew L., Corey L. 1988; Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection. Journal of Infectious Diseases 157:319–326
     [Google Scholar]
  72. Gönczöl E., Plotkin S. A. 1990; Progress in vaccine development for prevention of human cytomegalovirus infection. Current Topics in Microbiology and Immunology 54:254–274
     [Google Scholar]
  73. Gönczöl E., Hudecz F., Ianacone J., Dietzschold B., Starr S., Plotkin S. A. 1986; Immune responses to isolated human cytomegalovirus envelope proteins. Journal of Virology 58:661–664
     [Google Scholar]
  74. Gönczöl E., Ianacone J., Ho W., Starr S., Meignier B., Plotkin S. 1990; Isolated gA/gB glycoprotein complex of human cytomegalovirus induces humoral and cellular immune responses in human volunteers. Vaccine 8:130–136
     [Google Scholar]
  75. Gönczöl E., DeTaisne C., Hirka G., Berencsi K., Lin W., Paoletti E., Plotkin S. 1991; High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: the importance of the gB protein in HCMV immunity. Vaccine 9:631–637
     [Google Scholar]
  76. Gong M., Ooka T., Matsuo T., Kieff E. 1987; Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB. Journal of Virology 61:499–508
     [Google Scholar]
  77. Grefte A., Van Den Giessen M., Van Son W., The T. H. 1993; Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with active CMV infection. Journal of Infectious Diseases 167:210–277
     [Google Scholar]
  78. Grefte J. M. M., Van Der Gun B. T. F., Schmolke S., Van Der Giessen M., Van Son W. J., Plachter B., Jahn G., The T. H. 1992; The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. Journal of General Virology 73:2923–2932
     [Google Scholar]
  79. Gretch D. R., Kari B., Rasmussen L., Gehrz R. C., Stinski M. F. 1988a; Identification and characterization of three distinct families of glycoprotein complexes present in the envelope of human cytomegalovirus. Journal of Virology 63:875–881
     [Google Scholar]
  80. Gretch D. R., Gehrz R. C., Stinski M. F. 1988b; Characterization of a human cytomegalovirus glycoprotein complex (gel). Journal of General Virology 69:1205–1215
     [Google Scholar]
  81. Gretch D. R., Kari B., Gehrz R. C., Stinski M. F. 1988c; A multi-gene family encodes the human cytomegalovirus glycoprotein complex gcll (gp47-52 complex). Journal of Virology 62:1956–1962
     [Google Scholar]
  82. Gretch D. R., Bale J. F. Jr Gehrz R. C., Stinski M. F. 1991; Expression of a human cytomegalovirus glycoprotein multigene family. Virus Genes 5:203–214
     [Google Scholar]
  83. Grundy J. E., McKeating J. A., Ward P. J., Sanderson A. R., Griffiths P. D. 1987; β 2-Microglobulin enhances the infectivity of cytomegalovirus and when bound to the virus enables class I HLA molecules to be used as a virus receptor. Journal of General Virology 68:793–803
     [Google Scholar]
  84. Gupta P., St Jeor S., Rapp F. 1977; Comparison of the polypeptides of several strains of human cytomegalovirus. Journal of General Virology 34:447–454
     [Google Scholar]
  85. Hayes K., Alford C., Britt W. 1987; Antibody response to virus-encoded proteins after cytomegalovirus mononucleosis. Journal of Infectious Diseases 156:615–621
     [Google Scholar]
  86. Hoshi N., Tanaka S., Kimura M., Watanabe Y. 1987; Human monoclonal antibody to a 65 kDa structural polypeptide of cytomegalovirus. Kansenshogakuzasshi 61:871–878
     [Google Scholar]
  87. Hutchinson L., Browne H., Wargent V., Davis-Poynter N., Primorac S., Goldsmith K., Minson A. C., Johnson D. C. 1992; A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. Journal of Virology 66:2240–2250
     [Google Scholar]
  88. Irmiere A., Gibson W. 1983; Isolation and characterization of a noninfectious virion-like particle released from the cells infected with human strains of cytomegalovirus. Virology 130:118–133
     [Google Scholar]
  89. Irmiere A., Gibson W. 1985; Isolation of human cytomegalovirus intranuclear capsids, characterization of their protein constituents and demonstration that the B-capsid assembly protein is also abundant in noninfectious enveloped particles. Journal of Virology 56:277–283
     [Google Scholar]
  90. Jahn G., Mach M. 1990; Human cytomegalovirus phospho-proteins and glycoproteins and their coding regions. Current Topics in Microbiology and Immunology 54:171–185
     [Google Scholar]
  91. Jahn G., Kouzarides T., Mach M., Plachter B., Traupe B., Preddie E., Satchwell S. C., Fleckenstein B., Barrell B. G. 1987a; Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus. Journal of Virology 61:1358–1367
     [Google Scholar]
  92. Jahn G., Scholl B. -C., Traupe B., Fleckenstein B. 1987b; The two major structural phosphoproteins (pp65 and ppl50) of human cytomegalovirus and their antigenic properties. Journal of General Virology 68:1327–1337
     [Google Scholar]
  93. Jones T. R., Muzithras V. P. 1992; A cluster of dispensable genes within the human cytomegalovirus genome short component: IRS1, US1 through US5, and the US6 family. Journal of Virology 66:2541–2546
     [Google Scholar]
  94. Jones T. R., Muzithras V. P., Gluzman Y. 1991; Replacement mutagenesis of the human cytomegalovirus genome: US 10 and US 11 gene products are nonessential. Journal of Virology 65:5860–5872
     [Google Scholar]
  95. Kari B., Gehrz R. 1988; Isolation and characterization of a human cytomegalovirus glycoprotein containing a high amount of O-glycosidically linked oligosaccharides. Archives of Virology 98:171–188
     [Google Scholar]
  96. Kari B., Gehrz R. 1991; Biochemical and immunological analysis of discontinuous epitopes in the family of human cytomegalovirus glycoprotein complexes designated gC-I. Journal of General Virology 72:1975–1983
     [Google Scholar]
  97. Kari B., Gehrz R. 1992; A human cytomegalovirus complex designated gC-II is the major heparin-binding component of the envelope. Journal of Virology 66:1761–1764
     [Google Scholar]
  98. Kari B., Gehrz R. 1993; Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II. Journal of General Virology 74:255–264
     [Google Scholar]
  99. Kari B., Lussenhop N., Goertz R., Wabuke-Bunoti M., Radeke R., Gehrz R. 1986; Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes. Journal of Virology 60:345–352
     [Google Scholar]
  100. Kari B., Liu Y. -N. C., Goertz R., Lussenhop N., Stinski M. F., Gehrz R. 1990a; Structure and composition of a family of human cytomegalovirus glycoprotein complexes designated gC-I (gB). Journal of General Virology 71:2673–2680
     [Google Scholar]
  101. Kari B., Goertz R., Gehrz R. 1990b; Characterization of cytomegalovirus glycoproteins in a family of complexes designated gC-II with murine monoclonal antibodies. Archives of Virology 112:55–65
     [Google Scholar]
  102. Kaye J., Browne H., Stoffel M., Minson T. 1992a; The UL16 gene of human cytomegalovirus encodes a glycoprotein that is dispensable for growth in vitro . Journal of Virology 66:6609–6615
     [Google Scholar]
  103. Kaye J. F., Gompels U. A., Minson A. C. 1992b; Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. Journal of General Virology 73:2693–2698
     [Google Scholar]
  104. Keay S., Baldwin B. 1991; Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment. Journal of Virology 65:5124–5128
     [Google Scholar]
  105. Keay S., Merigan T. C., Rasmussen L. 1989; Identification of cell surface receptors for the 86-kilodalton glycoprotein of human cytomegalovirus. Proceedings of the National Academy of Sciences, U.S.A 86:10100–10103
     [Google Scholar]
  106. Kim K. S., Sapienza V. J., Carp R. I., Moon H. M. 1976; Analysis of structural polypeptides of purified human cytomegalovirus. Journal of Virology 20:604–611
     [Google Scholar]
  107. Kim K. S., Moon H. M., Sapienza V. J., Carp R. I. 1977; Complement fixing antigen of human cytomegalovirus. Journal of Infectious Diseases 135:281–288
     [Google Scholar]
  108. Kim K. S., Sapienza V. J., Chen C. M. J., Wisniewski K. 1983; Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus. Journal of Clinical Microbiology 18:331–343
     [Google Scholar]
  109. Kitamura K., Yamada K., Kuzuseiima K., Morishima T., Morishima Y., Yamamoto N., Nishiyama Y., Ohya K., Yamaguchi H. 1990; Human monoclonal antibodies to human cytomegalovirus derived from peripheral blood lymphocytes of healthy adults. Journal of Medical Virology 32:60–66
     [Google Scholar]
  110. Klages S., Ruger B., Jahn G. 1989; Multiplicity dependent expression of the predominant phosphoprotein pp65 of human cytomegalovirus. Virus Research 12:159–168
     [Google Scholar]
  111. Kniess N., Mach M., Fay J., Britt W. J. 1991; Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus. Journal of Virology 65:138–146
     [Google Scholar]
  112. Kollert-Jons A., Bogner E., Radsak K. 1991; A 15-kilobase-pair region of the human cytomegalovirus genome which includes US1 through US13 is dispensable for growth in cell culture. Journal of Virology 65:5184–5189
     [Google Scholar]
  113. Kropff B., Landini M. P., Mach M. 1993; Neutralizing activity of human sera correlates with antibody levels against selected antigenic domains on glycoprotein gp58/116. 4th International CMV Conference, Paris, France,19 to 21 April 1993 Abstract no 133
     [Google Scholar]
  114. Lahijani R. S., Otteson E. W., St Jeor S. C. 1992; A possible role for nonsense suppression in the synthesis of a human cytomegalovirus 58-kDa protein. Virology 186:309–312
     [Google Scholar]
  115. Lahijani R. S., Otteson E. W., Adlish J. D., St Jeor S. C. 1991; Characterization of a human cytomegalovirus 1·6 kilobase late mRNA and identification of its putative protein product. Journal of Virology 65:373–381
     [Google Scholar]
  116. Landini M. P., Michelson S. 1988; Human cytomegalovirus proteins. Progress in Medical Virology 35:152–185
     [Google Scholar]
  117. Landini M. P., Spaete R. R. 1993; Human cytomegalovirus structural proteins: a report of the first nomenclature workshop. In Multidisciplinary Approach to Understanding Cytomegalovirus Disease pp. 65–74 Michelson S., Plotkin S. A. Edited by Amsterdam: Excerpta Medica;
     [Google Scholar]
  118. Landini M. P., Re M. C., Mirolo G., Baldassarri B., La Placa M. 1985; Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting. Journal of Medical Virology 17:303–311
     [Google Scholar]
  119. Landini M. P., Mirolo G., Coppolecchia P., Re M. C., La Placa M. 1986; Serum antibodies to individual cytomegalovirus structural polypeptides in renal transplant recipients during viral infection. Microbiology and Immunology 30:683–695
     [Google Scholar]
  120. Landini M. P., Severi B., Furlini G., Badiali L. 1987; Human cytomegalovirus structural components: intracellular and intraviral localization of p28 and p65-69 by immuno-electron microscopy. Virus Research 8:15–23
     [Google Scholar]
  121. Landini M. P., Baldassarri B., Mirolo G., Ripalti A., La placa M. 1988a; Reactivity of cytomegalovirus structural polypeptides with different subclasses of IgG present in human sera. Journal of Infectious Diseases 16:163–167
     [Google Scholar]
  122. Landini M. P., Rossier E., Schmitz H. 1988b; Antibodies to human cytomegalovirus structural polypeptides during primary infection. Journal of Virological Methods 22:309–317
     [Google Scholar]
  123. Landini M. P., Lazzarotto T., Ripalti A., Guan M. X., La Placa M. 1989; Antibody response to recombinant lambda gtll fusion proteins in cytomegalovirus infection. Journal of Clinical Microbiology 27:2324–2327
     [Google Scholar]
  124. Landini M. P., Guan M. X., Jahn G., Lindenmaier W., Mach M., Ripalti A., Necker A., Lazzarotto T., Plachter B. 1990; Cytomegalovirus recombinant antigens: large scale screening with human sera. Journal of Clinical Microbiology 28:1375–1379
     [Google Scholar]
  125. Landini M. P., Ripalti A., Sra K., Pouletty P. 1991a; Human cytomegalovirus structural proteins: immune reaction against ppl50 synthetic peptides. Journal of Clinical Microbiology 29:1868–1872
     [Google Scholar]
  126. Landini M. P., Severi B., Cenacchi G., Lazzarotto T., Lindenmaier W., Necker A. 1991b; Human cytomegalovirus structural components: intracellular and intraviral localization of p28 and p6569 by immunoelectron-microscopy. Virus Research 8:15–23
     [Google Scholar]
  127. Landini M. P., Lazzarotto T., Percivalle E., Ripalti A., Gerna G. 1991c; Evidence that human cytomegalovirus assembly protein shares antigenic sites with an uninfected cell membrane protein. Journal of General Virology 72:3009–3016
     [Google Scholar]
  128. Law K. M., Wilton-Smith P., Farrar G. H. 1985; A murine monoclonal antibody recognising a single glycoprotein within a human cytomegalovirus virion envelope glycoprotein complex. Journal of Medical Virology 17:255–266
     [Google Scholar]
  129. Lawrence G. L., Chee M., Craxton M. A., Gompels U. A., Honess R. W., Barrell B. G. 1990; Human herpesvirus 6 is closely related to human cytomegalovirus. Journal of Virology 64:287–299
     [Google Scholar]
  130. Lee J. Y., Irmiere A., Gibson W. 1988; Primate cytomegalovirus assembly: evidence that DNA packaging occurs subsequent to B capsid assembly. Virology 167:87–96
     [Google Scholar]
  131. Lehner R., Meyer H., Mach M. 1989; Identification and characterization of a human cytomegalovirus gene coding for a membrane protein that is conserved among human herpesviruses. Journal of Virology 63:3792–3800
     [Google Scholar]
  132. Lehner R., Stamminger T., Mach M. 1991; Comparative sequence analysis of human cytomegalovirus strains. Journal of Clinical Microbiology 29:2494–2502
     [Google Scholar]
  133. Lery X., Chardonnet Y., Revillard J. P. 1982; Antigenic polypeptides of three reference strains recognized by sera from cytomegalovirus infected patients. Developments in Biological Standardization 52:359–366
     [Google Scholar]
  134. Lindenmaier W., Necker A., Krause S., Bonewald R., Collins J. 1990; Cloning and characterization of major antigenic determinants of human cytomegalovirus AD 169 seen by the human immune system. Archives of Virology 113:1–16
     [Google Scholar]
  135. Liu B., Stinski M. 1992; Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. Journal of Virology 66:4434–4444
     [Google Scholar]
  136. Liu Y. -N. C., Kari B., Gehrz R. C. 1988a; Immune responses to major human cytomegalovirus glycoprotein complexes. Journal of Virology 62:1066–1070
     [Google Scholar]
  137. Liu Y. -N. C., Eckhardt J., Kari B., Gehrz R. C. 1988b; General characterization of human cytomegalovirus-specific proliferative CD4+ T cell clones. International Journal of Cell Cloning 6:352–364
     [Google Scholar]
  138. Liu Y. -N. C., Klaus A., Kari B., Stinski M. F., Eckhardt J., Gehrz R. C. 1991; The N-terminal half of the envelope glycoprotein gB of human cytomegalovirus stimulates both B and T cell immune responses in humans. Journal of Virology 65:1644–1648
     [Google Scholar]
  139. Lucas G., Seigneurin J. M., Tamalat J., Michelson S., Baccard M., Delagneau J. F., Deletoille P. 1988; Cytomegalovirus (CMV): rapid diagnosis by indirect immunofluorescence assay using monoclonal antibody F6b-95/12 in a commercially available kit. Journal of Clinical Microbiology 27:367–369
     [Google Scholar]
  140. Lussenhop N. O., Goertz R., Wabuke-Bunoti M., Gehrz R., Kari B. 1988; Epitope analysis of human cytomegalovirus glycoprotein complexes using murine monoclonal antibodies. Virology 164:362–372
     [Google Scholar]
  141. McGeoch D. J., Dalrymple M. A., Davison A. J., Dolan A., Frame M. C., McNab D., Perry L. J., Scott J. E., Taylor P. 1988; The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. Journal of General Virology 69:1531–1574
     [Google Scholar]
  142. Mach M., Utz U., Fleckenstein B. 1986; Mapping of the major glycoprotein gene of human cytomegalovirus. Journal of General Virology 67:1461–1467
     [Google Scholar]
  143. Marshall G. S., Ricciardi R. P., Rando R. F., Puck J., Ge R., Plotkin S. A., Gönczöl E. 1990; An adenovirus recombinant that expresses the human cytomegalovirus major envelope glycoprotein and induces neutralizing antibodies. Journal of Infectious Diseases 162:1177–1181
     [Google Scholar]
  144. Marshall G. S., Rabalais G. P., Stout G. G., Waldeyer S. L. 1992; Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity. Journal of Infectious Diseases 165:381–384
     [Google Scholar]
  145. Martinez M. E., St Jeor S. C. 1986; Molecular cloning and analysis of three cDNA clones homologous to human cytomegalovirus RNAs present during late infection. Journal of Virology 60:531–538
     [Google Scholar]
  146. Martinez M. E., Lahijani R. S., St Jeor S. C. 1989; Analysis of a region of the human cytomegalovirus (AD 169) genome coding for a 25-kilodalton virion protein. Journal of Virology 63:233–241
     [Google Scholar]
  147. Mettenleiter T. C., Saalmuller A., Weiland F. 1993; Pseudorabies virus protein homologous to herpes simplex virus type 1 ICP 18.5 is necessary for capsid maturation. Journal of Virology 67:1236–1245
     [Google Scholar]
  148. Meyer H., Bankier A., Landini M. P., Ruger B., Mach M. 1988; Identification and prokaryotic expression of the gene coding for the highly immunogenic 28 kDa structural phosphoprotein (pp28) of human cytomegalovirus. Journal of Virology 62:2243–2250
     [Google Scholar]
  149. Meyer H., Masuho Y., Mach M. 1990; The gpl 16 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope. Journal of General Virology 71:2443–2450
     [Google Scholar]
  150. Meyer H., Sundqvist V. -A., Pereira L., Mach M. 1992; Glycoprotein gpl 16 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies. Journal of General Virology 73:2375–2383
     [Google Scholar]
  151. Michelson S., Tardy-Panit M., Barzu O. 1984; Properties of an human cytomegalovirus-induced protein kinase. Virology 134:259–268
     [Google Scholar]
  152. Michelson S., Tardy-Panit M., Barzu O. 1985; Catalytic properties of a human cytomegalovirus-induced protein kinase. European Journal of Biochemistry 149:393–399
     [Google Scholar]
  153. Michelson S., Tardy-Panit M., Colimon R., Landini M. P. 1989; A human cytomegalovirus-neutralizing monoclonal antibody recognizes a normal cell protein. Journal of General Virology 70:673–684
     [Google Scholar]
  154. Mocarski E. S. Jr 1993; Cytomegalovirus biology and replication. In The Human Herpesviruses pp. 173–226 Roizman B., Whitley R. J., Lopez C. Edited by New York: Raven Press;
     [Google Scholar]
  155. Navarro D., Paz P., Tugizov S., Topp K., Vail J. L., Pereira L. 1993; Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 197:143–158
     [Google Scholar]
  156. Neyts J., Snoeck R., Schols D., Balzarini J., Esko J. D., Schepdael A. V., Clercq E. D. 1992; Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology 189:48–58
     [Google Scholar]
  157. Novák J., Sova P., Krchňák V., Hamšíková E., Závadová H. 1991; Mapping of serologically relevant regions of human cytomegalovirus phosphoprotein ppl50 using synthetic peptides. Journal of General Virology 72:1409–1413
     [Google Scholar]
  158. Nowak B., Gmeiner A., Sarnow P., Levine A. J., Fleckenstein B. 1984a; Physical mapping of human cytomegalovirus genes: identification of DNA sequences coding for a virion phosphoprotein of 71 kDa and a viral 65 kDa polypeptide. Virology 134:91–102
     [Google Scholar]
  159. Nowak B., Sullivan C., Sarnow P., Thomas R., Bricout F., Nicolas F. C., Fleckenstein B., Levine A. J. 1984b; Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Virology 132:325–338
     [Google Scholar]
  160. Nowlin D. M., Cooper N. R., Compton T. 1991; Expression of a human cytomegalovirus receptor correlates with infectibility of cells. Journal of Virology 65:3114–3121
     [Google Scholar]
  161. Ohlin M., Sundqvist V. -A., Gilljam G., Ruden U., Gombert F. O., Wahren B., Borrebaeck C. A. K. 1991; Characterization of human monoclonal antibodies directed against the pp65-kDa matrix antigen of human cytomegalovirus. Clinical and Experimental Immunology 84:508–514
     [Google Scholar]
  162. Ohlin M., Sundqvist V. -A., Mach M., Wahren B., Borrebaeck C. A. K. 1993; Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies. Journal of Virology 67:703–710
     [Google Scholar]
  163. Pachl C., Probert W. S., Hermsen K. M., Masiarz F. R., Rasmussen L., Merigan T. C., Spaete R. R. 1989; The human cytomegalovirus strain Towne glycoprotein H gene encodes glycoprotein p86. Virology 169:418–426
     [Google Scholar]
  164. Pande H., Baak S. W., Riggs A. D., Clark B. R., Shively J. E., Zaia J. A. 1984; Cloning and physical mapping of a gene fragment coding for a 64 kDa major late antigen of human cytomegalovirus. Proceedings of the National Academy of Sciences, U.S.A 81:4965–4969
     [Google Scholar]
  165. Pande H., Campo K., Churchill M. A., Clark B. R., Zaia J. A. 1988; Genomic localization of a gene coding for a 32-kDa capsid protein of human cytomegalovirus. Virology 167:306–310
     [Google Scholar]
  166. Pande H., Lee T. D., Churchill M. A., Zaia J. A. 1990; Structural analysis of a 64 kDa major structural protein of human cytomegalovirus (Towne): identification of a phosphorylation site and comparison to pp65 of HCMV (AD169). Virology 178:6–14
     [Google Scholar]
  167. Pande H., Campo K., Tanamachi B., Zaia J. A. 1991; Human cytomegalovirus strain Towne pp65 gene: nucleotide sequence and expression in Escherichia coli . Virology 182:220–228
     [Google Scholar]
  168. Pereira L., Hoffman M. 1986; Immunology of human cytomegalovirus glycoproteins. In Human Herpesvirus Infections pp. 69–92 Lopez C., Roizman B. Edited by New York: Raven Press;
     [Google Scholar]
  169. Pereira L., Hoffman M., Gallo D., Cremer N. 1982a; Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants. Infection and Immunity 36:924–932
     [Google Scholar]
  170. Pereira L., Hoffman M., Cremer N. 1982b; Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera. Infection and Immunity 36:933–942
     [Google Scholar]
  171. Pereira L., Stagno S., Hoffman M., Volanakis J. E. 1983; Cytomegalovirus-infected cell polypeptides immune-precipitated by sera from children with congenital and perinatal infections. Infection and Immunity 39:100–108
     [Google Scholar]
  172. Pereira L., Hoffman M., Tatsuno M., Dondero D. 1984; Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies. Virology 139:73–86
     [Google Scholar]
  173. Plachter B., Klages S., Hagelmann S., Britt W., Landini M. P., Jahn G. 1990; Procaryotic expression of phosphorylated tegument protein pp65 of human cytomegalovirus and application of recombinant peptides for immunoblot analyses. Journal of Clinical Microbiology 28:1229–1235
     [Google Scholar]
  174. Plachter B., Wieczorek L., Scholl B. C., Ziegelmaier R., Jahn G. 1992; Detection of cytomegalovirus antibodies by an enzyme-linked immunosorbent assay using recombinant polypeptides of the large phosphorylated protein ppl50. Journal of Clinical Microbiology 30:201–206
     [Google Scholar]
  175. Porath A., Hanuka N., Keynan A., Sarov I. 1987; Virus-specific IgG, IgM, and IgA antibodies in cytomegalovirus mononucleosis patients as determined by immunoblotting technique. Journal of Medical Virology 22:223–230
     [Google Scholar]
  176. Qadri I., Navarro D., Paz P., Pereira L. 1992; Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus. Journal of General Virology 73:2913–2921
     [Google Scholar]
  177. Radsak K., Brücher K. H., Britt W., Shiou H., Schneider D., Kolbert A. 1990; Nuclear compartmentalization of glycoprotein B of human cytomegalovirus. Virology 177:515–522
     [Google Scholar]
  178. Rasmussen L. 1990; Immune response to human cytomegalovirus infection. Current Topics in Microbiology and Immunology 154:221–254
     [Google Scholar]
  179. Rasmussen L. E., Nelson R. M., Kelsall D. C., Merigan T. C. 1984; Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus. Proceedings of the National Academy of Sciences, U.S.A 81:876–880
     [Google Scholar]
  180. Rasmussen L., Mullenax J., Nelson R., Merigan T. C. 1985; Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus. Journal of Virology 55:274–280
     [Google Scholar]
  181. Rasmussen L., Nelson M., Neff M., Merigan T. C. Jr 1988; Characterization of two different human cytomegalovirus glycoproteins which are targets for virus neutralizing antibody. Virology 163:308–318
     [Google Scholar]
  182. Rasmussen L., Matkin C., Spaete R., Pachl C., Merigan T. C. 1991a; Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans. Journal of Infectious Diseases 164:835–842
     [Google Scholar]
  183. Rasmussen L., Resta S., Merigan T. C. 1991b; Human cytomegalovirus glycoprotein-receptor interactions. Transplantation Proceedings 23: Supplement 3 60–63
     [Google Scholar]
  184. Re M. C., Coppolecchia P., Furlini G., La Placa M. 1985; A 28000 molecular weight human cytomegalovirus structural polypeptide studied by means of a specific monoclonal antibody. Journal of General Virology 66:2507–2511
     [Google Scholar]
  185. Redmond M. J., Leyritz-Wills M., Winger L., Scraba D. G. 1986; The selection and characterization of human monoclonal antibody to human cytomegalovirus. Journal ofVirological Methods 14:9–24
     [Google Scholar]
  186. Revello M. G., Percivalle E., Di Matteo A., Morini F., Gerna G. 1992; Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients. Journal of General Virology 73:437–442
     [Google Scholar]
  187. Riddell S. R., Rabin M., Geballe A. P., Britt W. J., Greenberg P. D. 1991; Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. Journal of Immunology 146:2795–2804
     [Google Scholar]
  188. Ripalti A., Mocarski E. S. 1991; The products of human cytomegalovirus genes UL1-UL7, including gp48, are dispensable for growth in cell culture. In Progress in Cytomegalovirus Research pp. 57–60 Landini M. P. Edited by Amsterdam: Elsevier;
     [Google Scholar]
  189. Ripalti A., Landini M. P., Mocarski E. S., La Placa M. 1989; Identification and preliminary use of recombinant lambda gtll fusion proteins in cytomegalovirus diagnosis. Journal of General Virology 70:1247–1251
     [Google Scholar]
  190. Robson L., Gibson W. 1989; Primate cytomegalovirus assembly protein: genome location and nucleotide sequence. Journal of Virology 63:669–676
     [Google Scholar]
  191. Roby C., Gibson W. 1986; Characterization of phosphoproteins and protein kinase activity of virions, non-infectious enveloped particles and dense bodies of human cytomegalovirus. Journal of Virology 59:714–727
     [Google Scholar]
  192. Rodgers B. C., Mundin J., Sissons J. G. P. 1985; Monoclonal antibodies recognizing early and late antigens of human cytomegalovirus : heterogeneity of polypeptides recognized between virus isolates. Journal of General Virology 66:2045–2049
     [Google Scholar]
  193. Roizman B. 1993; The Family Herpesviridae in The Human Herpesviruses . pp. 1–9 Roizman B., Whitley R. J., Lopez C. Edited by New York: Raven Press;
     [Google Scholar]
  194. Roizman B., Sears A. E. 1990; Herpes simplex viruses and their replication. In Virology, 2nd edn. pp. 1795–1841 Fields B. N., Knipe D. M. Edited by New York: Raven Press;
     [Google Scholar]
  195. Roy D. M., Grundy J. E., Emery V. C. 1993; Sequence variation within neutralizing epitopes of the envelope glycoprotein B of human cytomegalovirus: comparison of isolates from renal transplant recipients and AIDS patients. Journal of General Virology 74:2499–2505
     [Google Scholar]
  196. Rudolph S. -A., Kühn J. E., Korn K., Braun R. W., Jahn G. 1990a; Prokaryotic expression of the major capsid protein of human cytomegalovirus and antigenic cross-reactions with herpes simplex virus type 1. Journal of General Virology 71:2023–2031
     [Google Scholar]
  197. Rudolph S. A., Stamminger T., Jahn G. 1990b; Transcriptional analysis of the eight kilobase mRNA encoding the major capsid protein of human cytomegalovirus. Journal of Virology 64:5167–5172
     [Google Scholar]
  198. Ruger B., Klages S., Walla B., Albrecht J., Fleckenstein B., Tomlinson P., Barrell B. 1987; Primary structure and transcription of a gene coding for the two virion phosphoproteins pp65 and ppTl of human cytomegalovirus. Journal of Virology 61:446–453
     [Google Scholar]
  199. Schleiss M. R., Degnin C. R., Geballe A. P. 1991; Translational control of human cytomegalovirus gp48 expression. Journal of Virology 65:6782–6789
     [Google Scholar]
  200. Schmidt H., Müller-Lantzch N., Peteler G. 1980; Human immune response to proteins of cytomegalovirus. Intervirology 13:154–161
     [Google Scholar]
  201. Schmitz H., Doerr H. W., Obrig M. 1975; Envelope and nucleocapsid antigens of cytomegalovirus. Medical Microbiology and Immunology 161:155–162
     [Google Scholar]
  202. Schmolke S., Drescher P., Jahn G., Plachter B. 1993; Intracellular transport of the matrix protein pp65 of HCMV. 4th International CMV Conference, Paris, France, 19 to 21 April 1993 Abstract no 183
     [Google Scholar]
  203. Scholl B. -C., Von Hintzenstern J., Borisch B., Traupe B., Bröker M., Jahn G. 1988; Prokaryotic expression of immunogenic polypeptides of the large phosphoprotein (ppl50) of human cytomegalovirus. Journal of General Virology 69:1195–1204
     [Google Scholar]
  204. Sedarati F., Rosenthal L. J. 1988; Isolation and partial characterization of nucleocapsid forms from cells infected with human cytomegalovirus strain AD 169 and Towne. Intervirology 29:86–100
     [Google Scholar]
  205. Severi B., Landini M. P., Govoni E. 1988; Human cytomegalovirus morphogenesis: an ultrastructural study of the late cytoplasmic phases. Archives of Virology 98:51–64
     [Google Scholar]
  206. Shenk P., Woods A. S., Gibson W. 1991; The 45 kilodalton protein of cytomegalovirus (Colburn) B-capsids is an amino-terminal extension form of the assembly protein. Journal of Virology 65:1525–1529
     [Google Scholar]
  207. Shimokawa K., Muruyama T., Ishida S., Furukawa T. 1987; Analysis by immunoblotting of human cytomegalovirus antibody in sera of renal transplant recipients. Journal of Medical Virology 21:339–346
     [Google Scholar]
  208. Shimokawa K., Bin X., Furukawa T. 1988; Comparative study with monospecific and monoclonal antibodies against a 65 kDa human cytomegalovirus protein. Archives of Virology 101:79–86
     [Google Scholar]
  209. Shuster E. A., Beneke J., Tegtmeier G. R., Pearson G. R., Gleaves A. D., Wold A. D., Smith T. F. 1985; Monoclonal antibodies for rapid laboratory detection of cytomegalovirus infections: characterization and diagnostic application. Mayo Clinic Proceedings 60:577–585
     [Google Scholar]
  210. Silvestri M., Sundqvist V. -A., Rudén U., Wahren B. 1991; Characterization of a major antigenic region on gp55 of human cytomegalovirus. Journal of General Virology 72:3017–3023
     [Google Scholar]
  211. Simpson J. A., Chow J. C., Baker J., Avdalovic N., Yuan S., Au D., Co M. S., Vasquez M., Britt W. J., Coelingh K. L. 1993; Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites. Journal of Virology 67:489–496
     [Google Scholar]
  212. Siqueira-Linhares M. I., Faucon-Biquet N., Chardonnet Y., Revillard J. P. 1981; Polypeptides and major antigens of four new isolates of cytomegalovirus. Medical Microbiology and Immunology 169:197–208
     [Google Scholar]
  213. Smith J. D. 1980; An additional role for the outer nuclear membrane in the morphogenesis of herpes simplex virus. Intervirology 13:312–316
     [Google Scholar]
  214. Söderberg C., Larsson S., Bergstedt-Lindqvist S., Miller E. 1993a; Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. Journal of Virology 67:3166–3175
     [Google Scholar]
  215. Söderberg C., Giugni T. D., Zaia J. A., Larsson S., Wahlberg J. M., Möller E. 1993b; CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. Journal of Virology 67:6576–6585
     [Google Scholar]
  216. Somogyi T., Michelson S., Masse M. -J. 1990; Genome location of a human cytomegalovirus protein with protein kinase activity (PK68). Virology 174:276–285
     [Google Scholar]
  217. Spaete R. R. 1991; A recombinant subunit vaccine approach to HCMV vaccine development. Transplantation Proceedings 23:90–96
     [Google Scholar]
  218. Spaete R. R., Thayer R. M., Probert W. S., Masiarz F. R., Chamberlain S. H., Rasmussen L., Merigan T. C., Pachl C. 1988; Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology 167:207–225
     [Google Scholar]
  219. Spaete R. R., Saxena A., Scott P. I., Song G. J., Probert W. S., Britt W. J., Gibson W., Rasmussen L., Pachl C. 1990; Sequence requirements for proteolytic processing of glycoprotein B of human cytomegalovirus strain Towne. Journal of Virology 64:2922–2931
     [Google Scholar]
  220. Spaete R. R., Perot K., Scott P. I., Bauer D., Lee A. S., Scott M. H., Rasmussen L., Britt W. J., Pachl C. 1991; CMV (Towne) glycoprotein H (gH) is complexed with GRP78 and GRP94. In Progress in Cytomegalovirus Research pp. 133–136 Landini M. P. Edited by Amsterdam: Elsevier;
     [Google Scholar]
  221. Spaete R. R., Perot K., Scott P. I., Nelson J. A., Stinski M. F., Pachl C. 1993; Coexpression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface. Virology 193:853–861
     [Google Scholar]
  222. Stackpole C. W. 1969; Herpes-type virus of the frog renal adenocarcinoma. I: Virus development in tumour transplants maintained at low temperature. Journal of Virology 4:75–93
     [Google Scholar]
  223. Stannard L. M., Rider J. R., Farrar G. H. 1989; Morphology and distribution of gp52 on extracellular human cytomegalovirus (HCMV) supports biochemical evidence that it represents HCMV glycoprotein B. Journal of General Virology 70:1553–1560
     [Google Scholar]
  224. Stinski M. F. 1976; Human cytomegalovirus: glycoproteins associated with virions and dense bodies. Journal of Virology 19:594–609
     [Google Scholar]
  225. Stinski M. F. 1977; Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus. Journal of Virology 23:751–767
     [Google Scholar]
  226. Stinski M. F. 1978; Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus-induced polypeptides. Journal of Virology 26:686–701
     [Google Scholar]
  227. Stinski M. F. 1990; Cytomegalovirus and its replication. In Virology, 2nd edn.. pp. 1959–1980 Fields B. N., Knipe D. M. Edited by New York: Raven Press;
     [Google Scholar]
  228. Sutherland S., Crawford D. H., Wilson S. A., Morgan B., Azim T., Huehns E. R. 1987; Production and characterization of a human monoclonal antibody to cytomegalovirus and its use in an early nuclear fluorescence assay. Journal of Medical Virology 22:245–255
     [Google Scholar]
  229. Takekoshi M., Ihara S., Tanaka S., Maeda-Takekoshi F., Watanabe Y. 1987; A new human cytomegalovirus isolate has an invertible subsegment within its L component producing eight genome isomers. Journal of General Virology 68:765–776
     [Google Scholar]
  230. Takekoshi M., Maeda-Takekoshi F., Ihara S., Sakuma S., Watanabe Y. 1991; Site-specific stable insertion into the human cytomegalovirus genome of a foreign gene under the control of the SV40 promoter. Gene 101:209–213
     [Google Scholar]
  231. Taylor D. L., Fellows L. E., Farrar G. H., Nash R. J., Taylor-Robinson D., Mobberly M. A., Ryder T. A., Jeffries D. J., Tyms A. S. 1988; Loss of cytomegalovirus infectivity after treatment with castanospermine or related plant alkaloids correlates with aberrant glycoprotein synthesis. Antiviral Research 10:11–26
     [Google Scholar]
  232. Taylor H. P., Cooper N. R. 1989; Human cytomegalovirus binding to fibroblasts is receptor mediated. Journal of Virology 63:3991–3998
     [Google Scholar]
  233. Taylor H. P., Cooper N. R. 1990; The human cytomegalovirus receptor on fibroblasts is a 30-kilodalton membrane protein. Journal of Virology 64:2484–2490
     [Google Scholar]
  234. Tengelsen L. A., Pederson N. E., Shaver P. R., Wathen M. W., Homa F. 1993; Herpes simplex type 1 DNA cleavage and encapsidation require the product of the UL28 gene: isolation and characterization of two UL28 deletion mutants. Journal of Virology 67:3470–3480
     [Google Scholar]
  235. Tomiyama T., Matsumoto Y. -I., Sugano T., Fujinaga S., Masuho Y. 1990; Preparation of human monoclonal antibodies against a cytomegalovirus glycoprotein complex of 130 and 55 kDa. Journal of Immunological Methods 131:249–255
     [Google Scholar]
  236. Urban M., Britt W., Mach M. 1992; The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific. Journal of Virology 66:1303–1311
     [Google Scholar]
  237. Urban M., Winkler T., Landini M. P., Britt W., Mach M. 1994; Epitope-specific distribution of IgG subclasses against antigenic domains on glycoproteins of human cytomegalovirus. Journal of Infectious Diseases 169:83–90
     [Google Scholar]
  238. Utz U., Britt W., Vugler L., Mach M. 1989; Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. Journal of Virology 63:1995–2001
     [Google Scholar]
  239. Van Der Blj W., Schirm J., Torensma, Van Son W. J., Tegzess A., The T. H. 1988a; Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. Journal of Clinical Microbiology 26:2531–2535
     [Google Scholar]
  240. Van Der Blj W., Torensma R., Van Son W. J., Anema J., Schirm J., Tegzess A. M., The T. H. 1988b; Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes. Journal of Medical Virology 25:179–188
     [Google Scholar]
  241. Wagner B., Kropff B., Kalbacher H., Britt W., Sundqvist V. -A., Ostberg A., Mach M. 1992; A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus. Journal of Virology 66:5290–5297
     [Google Scholar]
  242. Weiner D., Gibson W. 1981; Identification of a primate CMV-group common antigen. Virology 115:182–191
     [Google Scholar]
  243. Weiner D., Gibson W., Fields K. 1985; Anti-complement immunofluorescence establishes nuclear localization of human cytomegalovirus matrix protein. Virology 147:19–28
     [Google Scholar]
  244. Welch A. R., McNally L. M., Gibson W. 1991a; Cytomegalovirus assembly protein nested gene family: four 3′-coterminal transcripts encode four in-frame, overlapping proteins. Journal of Virology 65:4091–4100
     [Google Scholar]
  245. Welch A. R., Woods A. S., McNally L. M., Cotter R. J., Gibson W. 1991b; A herpesvirus maturational proteinase, assemblin: identification of its gene, putative site domain and cleavage site. Proceedings of the National Academy of Sciences, U.S.A 88:10792–10796
     [Google Scholar]
  246. Wells D. E., Vugler L. G., Britt W. J. 1990; Structural and immunological characterization of human cytomegalovirus gp55-116 (gB) expressed in insect cells. Journal of General Virology 71:873–880
     [Google Scholar]
  247. Weston K., Barrell B. G. 1986; Sequence of the short unique region, short repeats, and part of the long repeats of human cytomegalovirus. Journal of Molecular Biology 192:177–208
     [Google Scholar]
  248. Yamanaka T., Kiyotani K., Sakaguchi T., Fukuda Y., Dohi K., Yamada M., Yoshida M., Nil S., Yoshida T. 1992; Detection of cytomegalovirus in urine samples by enzyme-linked immunosorbent assay using a monoclonal antibody against the viral 150 kDa protein. Journal of Clinical Microbiology 30:685–690
     [Google Scholar]
  249. Yamauchi M., Nishiyama Y., Fujioka H., Isomura S., Maeno K. 1985; On intracellular transport and the nuclear association of human cytomegalovirus structural proteins. Journal of General Virology 66:675–684
     [Google Scholar]
  250. Zaia J. A., Forman S. J., Ting Y. P., Vanderwal-Urbina E., Blume K. G. 1986; Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients. Journal of Infectious Diseases 153:780–787
     [Google Scholar]
  251. Zipeto D., Baldanti F., Percivalle E., Gerna G., Milanesi G. 1993; Identification of a human cytomegalovirus mutant in the ppl50 matrix phosphoprotein gene with a growth-defective phenotype. Journal of General Virology 74:1645–1648
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-12-3287
Loading
Human cytomegalovirus structural proteins
J. Gen. Virol. 75, 3287 (1994); https://doi.org/10.1099/0022-1317-75-12-3287
/content/journal/jgv/10.1099/0022-1317-75-12-3287
/content/journal/jgv/10.1099/0022-1317-75-12-3287
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error